Concepts of Computer-Aided Drug Design (CADD)

Comprehensive practice flashcards covering Concepts of Computer-Aided Drug Design (CADD), including molecular mechanics, quantum mechanics, drug design quadrants, ligand preparation, similarity searches, 2D and 3D QSAR, pharmacophore modeling, and receptor modeling.

At what specific point in the drug discovery pipeline is Computer-Aided Drug Design (CADD) generally performed?

CADD is generally performed between the stages of target validation and hit finding to identify hits from a library of chemicals.

What are the two primary molecular entities ("main players") involved in CADD evaluations?

The two main players are the ligand (the prospective drug being developed) and the drug target.

In which drug development stages are in silico and in vitro testing generally no longer needed, and what is the specific exception?

They are no longer needed during the preclinical and clinical stages; the exception is when developing an antibiotic in preclinical testing, which requires in vitro culture testing and determination of the minimum inhibitory concentration.

How does Molecular Mechanics differ from Quantum Mechanics in how it models molecular systems and computes properties?

Molecular Mechanics applies classical Newtonian laws to atomic nuclei while disregarding electrons entirely (ball-and-spring model runnable on low-end computers), whereas Quantum Mechanics treats matter at a subatomic level and explicitly calculates the motion of electrons (requiring high-end computers).

What is the primary difference in electron calculation between ab initio and semi-empirical quantum mechanical methods?

Ab initio rigorously calculates both core and valence electrons without stored parameters (highly accurate gold standard, but slow and restricted to small molecules), whereas semi-empirical methods compute only valence electrons while freezing or ignoring core electrons (faster approximations for larger molecules).

Based on the 2x2 CADD classification matrix shown, which design strategy is employed when the target protein structure is known but no active ligands exist yet?

De Novo Design, which builds entirely new drug molecules atom-by-atom directly into the binding site and utilizes virtual screening.

How do 3D grid lattices utilize probe atoms to measure molecular properties in CADD software?

A probe atom is positioned and moved around the contours and crevices of a molecule inside a 3D lattice to sample steric fields (steric hindrance) and electrostatic fields (detecting charged, electron-donating, or electron-withdrawing regions).

Why must water molecules be removed from computer simulations during molecular docking?

Water has a high dielectric constant that creates electrostatic interactions and masks the true partial charges of the drug molecule, which distorts the docking score calculation.

What is the purpose of energy minimization after initially drawing a molecular structure?

It uses a molecular mechanics program to adjust non-ideal, high-energy bond lengths, bond angles, and torsion angles until the molecule reaches its most stable, relaxed conformation (energy minimum).

In the indole/fluorobenzoyl complex shown, which component serves as the HOMO and which serves as the LUMO?

The indole system acts as the HOMO (Highest Occupied Molecular Orbital, electron donor), while the fluorobenzoyl system acts as the LUMO (Lowest Unoccupied Molecular Orbital, electron acceptor).

How does simulated spectroscopic data assist in identifying active antibacterial analogues of $\beta$-lactams?

CADD calculates theoretical infrared wavenumbers; if the characteristic peak for the active $\beta$-lactam ring shifts significantly away (e.g., from wavenumber $300$ to $200$ or $400$), it signifies that the essential antibacterial pharmacophore is not present.

What is the Similarity Property Principle (SPP), and what is its major limitation?

SPP asserts that similar compounds should have similar properties and biological activities; its major limitation is SAR discontinuity (activity cliffs), where small chemical modifications cause substantial changes in biological activity.

How do carbamazepine (CBZ), amitriptyline, and loratadine illustrate an "activity cliff"?

Despite sharing a common tricyclic core structure, slight substituent alterations give them completely different therapeutic activities: CBZ is an anticonvulsant, amitriptyline is a tricyclic antidepressant (TCA), and loratadine is an antihistamine ($H_1$ receptor antagonist).

Based on the structural feature table shown, how is the Tanimoto coefficient ($T_c$) calculated between aspirin (1) and salicylic acid (2)?

$T_c = \frac{A}{A + B + C} = \frac{3}{3 + 2 + 0} = 0.6$ (or $60\%$ similarity), where $A=3$ shared features, $B=2$ features unique to aspirin, and $C=0$ features unique to salicylic acid.

What numerical threshold value for the Tanimoto coefficient ($T_c$) has historically propagated in literature as a general benchmark for identical bioactivity?

A $T_c$ value of at least $0.85$ (or $85\%$ similarity).

In molecular structure overlays, what is Root Mean Square Distance (RMSD) and what range indicates high structural similarity?

RMSD measures spatial positional differences across all corresponding atoms; a lower RMSD value between $0$ and $1.50$ indicates higher similarity between the overlaid molecules.

Why is the rigid-body assumption utilized during molecular structure overlay computations?

Locking molecules in a fixed active conformation eliminates rotational freedom around single bonds, drastically speeding up computation time despite being less realistic.

Why are quinine and quinidine cited as evidence that structural similarity does not ensure identical pharmacological activity?

They are structurally related isomers differing only in stereochemistry at a single center, yet quinine is an antimalarial whereas quinidine is an antiarrhythmic.

How do cisplatin and transplatin differ regarding biological activity?

They differ only in the cis versus trans orientation of their amino and chloride groups, but only cisplatin is biologically active as a chemotherapeutic agent while transplatin is inactive.

What three core criteria must compounds meet to be validly included in a 2D QSAR study?

They must be structurally related, act at the same biological target, and share the same mechanism of action.

Why does the relationship between drug activity ($\log(1/C)$) and hydrophobicity ($\log(P)$) typically follow a bell-shaped curve rather than a linear increase?

Beyond an optimal lipophilicity ($\log(P)^0$), excessive hydrophobicity causes compounds to become poorly soluble in watery body fluids, trapped in fat depots, and overly bound to serum albumin, preventing effective transport and receptor access.

What is the general rule of thumb for optimal $\log(P)$ for CNS penetration, and how was Sulmazole designed relative to it?

Drugs targeting the CNS should have a $\log(P) \approx 2$. Sulmazole was intentionally designed with a lower $\log(P) = 1.17$ ($< 2$) so it remains in the systemic circulation and avoids CNS side effects (such as the "yellow vision" caused by cardiac drugs with high $\log(P)$, like $2.59$).

How is the substituent hydrophobicity constant ($\pi_X$) calculated for an aromatic substituent $X$?

It is calculated using $\pi_X = \log(P_X) - \log(P_H)$, where $P_X$ is the partition coefficient of the substituted compound and $P_H$ is that of the parent reference compound (e.g., chlorobenzene $\log(P) = 2.84$ minus benzene $\log(P) = 2.13$ gives $\pi = 0.71$).

In QSAR, what do positive versus negative Hammett substituent constants ($\sigma$) indicate about a substituent's electronic behavior?

Positive $\sigma$ values designate electron-withdrawing groups (EWGs; e.g., halogens, nitro) that facilitate ionization and hydrolysis, whereas negative $\sigma$ values designate electron-donating groups (EDGs; e.g., methyl, amino) that stabilize the ring and resist hydrolysis.

What physicochemical parameters do $\log(P)$, $\sigma$, and $E_s$ represent in the Hansch equation shown?

$\log(P)$ represents molecular hydrophobicity, $\sigma$ represents the Hammett electronic substituent constant, and $E_s$ represents Taft's steric factor.

How does the Free-Wilson approach differ from the Hansch equation in QSAR calculations?

The Free-Wilson approach directly correlates overall biological activity to substituent presence without requiring individual physicochemical constant tables ($\pi$, $\sigma$, $E_s$), making it computationally simpler but harder to explain mechanistically.

What is the primary role of the Topliss scheme in medicinal chemistry analogue development?

It serves as a step-by-step operational flow diagram guiding the synthesis of a small series of analogues when the number of existing compounds is too small to derive a reliable Hansch equation.

In the Craig plot shown, what parameters are mapped on the x-axis and y-axis?

The x-axis represents the substituent hydrophobicity factor ($\pi$), and the y-axis represents the Hammett electronic factor ($\sigma$).

What is the precise definition of a pharmacophore in drug design?

A pharmacophore is not a specific chemical compound or functional group, but an abstract 3D spatial template of essential steric and electronic features (binding centers) required for biological receptor interaction.

When Warfarin is aligned over the Vitamin K pharmacophore model shown, what specific chemical moieties fulfill the Van der Waals and Hydrogen Bond Acceptor features?

Its aromatic benzene rings satisfy the Van der Waals spheres via $\pi\text{-}\pi$ interactions, while its carbonyl oxygen acts as the required Hydrogen Bond Acceptor (HBA).

How does automatic identification software determine distinct pharmacophore candidates from a flexible lead molecule?

It defines potential binding centers across multiple generated conformations, forms geometric pharmacophore triangles between them, and plots their side lengths on a 3D coordinate graph where clusters indicate shared, distinct pharmacophores.

What is Comparative Molecular Field Analysis (CoMFA), and what is its core operating premise?

CoMFA is a 3D QSAR method that samples steric and electrostatic fields at thousands of lattice points surrounding aligned molecules, operating on the premise that noncovalent drug-receptor interactions correlate with variations in these field energies.

What are three fundamental differences between 2D QSAR and 3D QSAR?

2D QSAR outputs mathematical equations, is restricted to structurally similar congeners, and is retrospective; 3D QSAR outputs visual graphical contour maps, accommodates structurally diverse molecules, and is prospective for designing entirely new structures.

What is the primary technical limitation of X-ray crystallography when acquiring target structures for Structure-Based Drug Design (SBDD)?

Many important biological proteins, especially membrane-bound classes like G-protein coupled receptors (GPCRs) and ion channels, are extremely difficult to crystallize in the laboratory.

When is Homology Modelling utilized in CADD, and what primary criterion dictates template selection?

It is utilized when an experimental X-ray crystal structure of a target human protein is unavailable; template selection is based on finding a resolved protein structure from another organism that shares the highest amino acid sequence identity (e.g., $98\%–99\%$ via BLAST).